The protective effect of coronavirus disease 2019 (COVID-19) vaccination on postacute sequelae of COVID-19: a multicenter study from a large national health …

SN Zisis, JC Durieux, C Mouchati… - Open Forum …, 2022 - academic.oup.com
Abstract Background Coronavirus disease 2019 (COVID-19) vaccines have been proven to
decrease the severity of acute-phase infection; however, little is known about their effect on …

The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research

AR Marra, T Kobayashi, GY Callado, I Pardo… - Antimicrobial …, 2023 - cambridge.org
Objective: We performed a systematic literature review and meta-analysis on the
effectiveness of coronavirus disease 2019 (COVID-19) vaccination against post-COVID …

The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post–COVID-19 conditions: A systematic literature review and meta-analysis

AR Marra, T Kobayashi, H Suzuki… - Antimicrobial …, 2022 - cambridge.org
Background: Although multiple studies have revealed that coronavirus disease 2019
(COVID-19) vaccines can reduce COVID-19–related outcomes, little is known about their …

The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States

SM Moghadas, TN Vilches, K Zhang… - Clinical Infectious …, 2021 - academic.oup.com
Background Global vaccine development efforts have been accelerated in response to the
devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a …

[HTML][HTML] Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review

KI Notarte, JA Catahay, JV Velasco, A Pastrana… - …, 2022 - thelancet.com
Background Although COVID-19 vaccination decreases the risk of severe illness, it is
unclear whether vaccine administration may impact the prevalence of long-COVID. The aim …

Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis

AR Marra, T Kobayashi, H Suzuki, M Alsuhaibani… - Journal of Infection, 2022 - Elsevier
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …

[HTML][HTML] Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review

S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Reduced incidence of long-COVID symptoms related to administration of COVID-19 vaccines both before COVID-19 diagnosis and up to 12 weeks after

MA Simon, RD Luginbuhl, R Parker - MedRxiv, 2021 - medrxiv.org
Both clinical trials and studies leveraging real-world data have repeatedly confirmed the
three COVID-19 vaccines authorized for use by the Food and Drug Administration are safe …

[HTML][HTML] Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era

O Freund, L Tau, TE Weiss, L Zornitzki, S Frydman… - PLoS …, 2022 - journals.plos.org
Background The resurgence of COVID-19 cases since June 2021, referred to as the fourth
COVID-19 wave, has led to the approval and administration of booster vaccines. Our study …

Necessity of coronavirus disease 2019 (COVID-19) vaccination in persons who have already had COVID-19

NK Shrestha, PC Burke, AS Nowacki… - Clinical Infectious …, 2022 - academic.oup.com
Background The aim was to evaluate the necessity of coronavirus disease 2019 (COVID-19)
vaccination in persons with prior COVID-19. Methods Employees of the Cleveland Clinic …